Celldex Therapeutics, Inc.
CLDXNasdaqCIK 744218HealthcareFiscal year ends Dec 31
Reports and events: 259 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2211:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-109465 |
| 2026-08-0620:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-091984 |
| 2026-08-0620:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-005316 |
| 2026-07-1520:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-083880 |
| 2026-06-2612:43 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-078023 |
| 2026-05-0720:07 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-057113 |
| 2026-05-0720:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-003153 |
| 2026-04-2912:00 ET | DEF 14A | Proxy statementPeriod 2026-06-25 | 0001104659-26-050884 |
| 2026-04-0212:08 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-038882 |
| 2026-02-2521:06 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-019652 |
| 2026-02-2521:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-001098 |
| 2025-11-1021:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-109137 |
| 2025-11-1021:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-007179 |
| 2025-08-1920:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-080248 |
| 2025-08-0720:06 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001410578-25-001610 |
| 2025-08-0720:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-005181 |
| 2025-06-0612:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-057066 |
| 2025-05-0820:06 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001410578-25-001111 |
| 2025-05-0820:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-002980 |
| 2025-04-2112:01 ET | DEF 14A | Proxy statementPeriod 2025-06-05 | 0001104659-25-036562 |
| 2025-02-2721:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001410578-25-000216 |
| 2025-02-2721:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-001126 |
| 2024-11-0621:06 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001410578-24-001766 |
| 2024-11-0621:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-006056 |
| 2024-08-0820:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001410578-24-001219 |
| 2024-08-0820:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-004603 |
| 2024-06-1412:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-071512 |
| 2024-05-0620:07 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001410578-24-000593 |
| 2024-05-0620:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-002570 |
| 2024-04-2512:00 ET | DEF 14A | Proxy statementPeriod 2024-06-13 | 0001104659-24-051634 |
| 2024-03-0121:10 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-029969 |
| 2024-02-2612:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001410578-24-000076 |
| 2024-02-2612:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-000966 |
| 2023-11-0822:03 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-115796 |
| 2023-11-0614:00 ET | 8-K | 8.01 Other events | 0001104659-23-114520 |
| 2023-11-0220:06 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001410578-23-002169 |
| 2023-11-0220:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-006668 |
| 2023-08-0820:06 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001410578-23-001588 |
| 2023-08-0820:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-005101 |
| 2023-06-1520:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-23-071597 |
| 2023-05-0420:05 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001104659-23-055992 |
| 2023-05-0420:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-002887 |
| 2023-04-2512:01 ET | DEF 14A | Proxy statement | 0001104659-23-049299 |
| 2023-03-2222:47 ET | 8-K | 8.01 Other events | 0001104659-23-035198 |
| 2023-02-2821:06 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001104659-23-026701 |
| 2023-02-2821:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-001254 |
| 2023-02-2121:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-023768 |
| 2022-11-0921:07 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001104659-22-116466 |
| 2022-11-0921:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-22-007291 |
| 2022-08-0820:06 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001104659-22-087222 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:54 ET. Listed shows no prices and gives no investment advice.